Last updated on December 2019

A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Brief description of study

A randomized multi-arm study evaluating the safety and efficacy of abemaciclib or palbociclib and anastrozole with or without nivolumab in participants with ER+/HER2- breast cancer

Clinical Study Identifier: NCT04075604

Find a site near you

Start Over

Local Institution

Moenchengladbach, Germany
  Connect »